CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
207,116
Share change
-126,703
Total reported value
$755,965
Price per share
$3.65
Number of holders
7
Value change
-$733,655
Number of buys
4
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q3 2020

As of 30 Sep 2020, CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 207,116 shares. The largest 7 holders included SABBY MANAGEMENT, LLC, Raymond James Financial Services Advisors, Inc., WEDBUSH SECURITIES INC, Federation des caisses Desjardins du Quebec, UBS Group AG, WELLS FARGO & COMPANY/MN, and BREWIN DOLPHIN LTD. This page lists 7 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.